How intellectual property can help 3D printing support, not harm, medtech
3D printing, or additive manufacturing, is frequently, and rightly, hailed as the next revolution in technology.
Since its inception in 1986, 3D printing has transformed numerous sectors including aviation, manufacturing, and energy, and altered perceptions...
Considering a pharma and bioscience patent? The UK Intellectual Property Office maps out the...
Lawrence Cullen & Laura Starrs, Patent Examining Group Heads, IPO
Managing a patent portfolio requires, among many skills, the ability to anticipate the future. This is especially true in the fields of bioscience and pharma where,...
The baby brain scans that could help predict symptoms of autism and ADHD
London researchers are embarking on a three-year study aiming to identify babies at higher than average risk of autism spectrum conditions (ASC) and attention deficit hyperactivity disorder (ADHD).
The work at King’s College London is...
Research at the interface of technology and life sciences
Professor Jens Jordan, Director of the Institute of Aerospace Medicine
The Institute of Aerospace Medicine at the German Aerospace Center (DLR) comprises departments in Cologne and in Hamburg with internationally unique research infrastructure. At DLR, the...
A golden era for blood cancer treatments
It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...
Biological engineers discover new antibiotic candidates
The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body...
Cutting to the chase – how a folded piece of paper is saving lives
Around the world, many hundreds of millions of people are infected by parasitic diseases such as malaria and schistosomiasis. Many more millions of people are affected by the impact of these diseases with profound...
Patenting aerospace medicines – the final frontier?
Research and development (R&D) into aerospace medicine can be viewed as falling into one of two camps: that aimed at adapting an existing ‘terrestrial’ medicine for use in the aerospace environment; and that which...
Know your third party patent rights
In the competitive world of the biosciences, third party patent rights (TPRs) can stand in the way of a planned course of action, even after significant investment has been made. Knowledge of such rights...
The IP journey and risk mitigation
Paul Storer
Senior Policy Adviser in the Business Support Policy Team at the IPO
Resolving IP disputes can be costly and the Intellectual Property Office continues to seek to reduce costs for businesses, not only in...
The search for new antimicrobials
Few issues are more pressing than the global problem of antibiotic resistance, so we speak to Professor Mathew Upton, about his work searching for new antibiotics.
“For so long now, antibiotics have been seen as...
New research predicts a positive future for biosimilars
The prospect of reducing treatment costs for payors supports a positive future for biosimilars
Biosimilar approvals in the US market still significantly lag behind Europe despite an evolving regulatory landscape and three new...
A new way to manufacture small batches of biopharmaceuticals on demand
Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical industry. They’re increasingly important for “precision medicine” — drugs tailored toward the genetic or molecular...
Making Pharmaceuticals person-specific
Dr Mohammed Maniruzzaman: Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex
In this issue of BioScience Today, we speak to Dr Mohammed Maniruzzaman, Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex,...
UK-led study marks shift towards genetic era in tackling TB
In a landmark study that may herald a quicker, more tailored treatment for the millions of people around the world living with tuberculosis (TB), UK researchers have shown how our understanding of TB’s genetic...
New ‘trap’ to analyse, in real time, how cells communicate
Using multiple laser beams and Raman spectroscopy, experts at the Universities of Nottingham and Glasgow have designed and built a new instrument which could help scientists learn more about how infections take hold and...